Sunobinop 0.5 mg clinical trials

A Two-part, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 2 Study to Evaluate Impact of Sunobinop (V117957) on Alcohol Consumption (Part A) and Alcohol Craving (Part B) in Subjects Diagnosed with Moderate to Severe Alcohol Use Disorder and Seeking Treatment

This study is looking at a new medicine called Sunobinop to see if it can help people who want to cut down their drinking or stop drinking alcohol. It will check if the medicine helps reduce how much and how often people drink heavily.